ClinicalTrials.gg
CompletedNCT07578701Updated May 11, 2026

THE EFFECT OF CORRECTIVE EXERCISES ON Q ANGLE AND JUMP-LANDING MECHANICS

An interventional study of Structured Corrective Exercise Program in Genu Valgum, Biomechanical Phenomena and Athletic Injuries, sponsored by Istanbul Gelisim University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 14 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by Istanbul Gelisim University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Feb 2023, registered May 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
14 Years to 17 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 52 studies in Athletic Injuries with a site in Turkey — 10 open to participants now, 12 under way, none of them phase 3. Athletic Injuries · Turkey.

Enrollment
29th of 31
23 · median 44
Started
2023
with 7 others
No phase
31 of 52
6 open now
Registered
43rd of 52
by date
Lead sponsor
3 of 52
Istanbul Gelisim University

Among the 52 studies in Athletic Injuries with a site in Turkey, this one is the 29th largest by enrollment of the 31 interventional ones that give a count, is one of 8 that started in 2023, is one of 31 with no phase, and was the 43rd registered.

Athletic Injuries

258 studies on the registry are indexed under Athletic Injuries; 45 are open to participants now.

Browse Athletic Injuries studies →

Open to participants now

10 of the 52 studies in Athletic Injuries with a site in Turkey are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 21 Athletic Injuries studies recruiting now, 2 (10%) set no upper age limit and 18 (86%) stop at 75 or younger; 11 take children under 18; 8 take healthy volunteers.

This study: 14 Years to 17 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Athletic Injuries with a site in Turkey, or all of them as a file.
02

Study summary

This study examines the effects of an 8-week structured corrective exercise program on Q angle and jump-landing mechanics (evaluated via the Landing Error Scoring System - LESS) in competitive young female volleyball players during their in-season period. Twenty-three athletes were assigned to either an experimental group receiving corrective exercises or a control group maintaining standard training. The primary goal is to determine if targeted biomechanical corrections can improve knee alignment and movement quality to mitigate injury risks.

Read the detailed description

The intervention consists of a specialized corrective exercise program focused on body segment alignment and injury risk mitigation, performed over an 8-week duration. Assessments were conducted pre- and post-intervention, including:

Static Q angle measurements.

Biomechanical analysis using the Landing Error Scoring System (LESS).

Countermovement jump (CMJ) height to evaluate explosive power.

The study analyzes whether integrating these exercises into in-season training effectively reduces the Q angle and improves jump-landing mechanics compared to a control group performing only standard volleyball training.

03

Conditions studied

  • Genu Valgum
  • Biomechanical Phenomena
  • Athletic Injuries
  • Knee Injuries

Keywords

  • Volleyball
  • Q Angle
  • Landing
  • Corrective Exercises
  • Jump
04

Who can participate

Ages eligible
14 Years to 17 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Licensed young female volleyball players.

Aged between 14 and 17 years.

Willingness to participate voluntarily with parental and athlete consent.

Exclusion criteria

Exclusion Criteria:

History of major lower extremity injuries or orthopedic surgery.

Presence of any musculoskeletal or neurological condition that prevents participation in the exercise program.

Lack of regular attendance at volleyball training sessions.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Experimental Group

    Young female volleyball players (n=12) who participated in an 8-week structured corrective exercise program during the in-season period, in addition to their standard volleyball training

    Behavioral: Structured Corrective Exercise Program

  • No intervention
    Control Group

    Young female volleyball players (n=11) who continued their standard volleyball training during the 8-week study period without participating in any corrective exercise protocol.

Interventions

  • BehavioralStructured Corrective Exercise Program

    The corrective exercise program was implemented 3 times per week for 8 weeks during the in-season period. The protocol focused on optimizing lower extremity alignment, improving neuromuscular control, and correcting faulty jump-landing patterns. Key components included exercises targeting body segment alignment, specific drills to reduce the Q angle, and neuromuscular training to enhance Landing Error Scoring System (LESS) scores. All sessions were integrated into the athletes' regular volleyball training schedule to ensure proper kinetic chain integration and injury risk mitigation.

06

What researchers measure

Primary outcomes

  1. Static Q Angle

    The measurement of the angle between the quadriceps muscle and the patellar tendon to assess lower extremity alignment.

    Time frame: Baseline and at the end of the 8-week intervention.

  2. Landing Error Scoring System (LESS) Score

    A clinical tool used to assess jump-landing mechanics through video analysis.

    Time frame: Baseline and post-intervention (8 weeks).

  3. Countermovement Jump (CMJ) Height

    Measurement of vertical jump height to evaluate explosive power.

    Time frame: Baseline and post-intervention (8 weeks).

07

Study locations

1 site
  • Istanbul Gelisim University, Faculty of Sport Sciences
    Istanbul, 34310, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after de-identification, will be available from the corresponding author on reasonable request.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be available beginning 6 months after publication and ending 3 years after publication.

Access criteria: De-identified individual participant data will be available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal. Proposals should be directed to btas@gelisim.edu.tr. To gain access, data requestors will need to sign a data access agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2023 to primary completion in May 2024, 14 months.

Of 119 non-industry interventional studies with no phase under Athletic Injuries, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 14. This study's 14 months is above that.

Counting every sponsor, half of 121 studies reached it within 5 months; a quarter within 2 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2026
First posted
May 11, 2026
StartActual
Feb 20, 2023
Primary completionActual
May 10, 2024
CompletionActual
Jun 15, 2024
Last update
May 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07578701
Lead sponsor
Istanbul Gelisim University
Responsible party
Sponsor
First posted
May 11, 2026
Start date
Feb 20, 2023
Primary completion
May 10, 2024
Completion
Jun 15, 2024
Last update
May 11, 2026

Study contacts

Burak TAŞ, PhD
principal investigator · Istanbul Gelisim University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion